DISPOSITION OF CLOZAPINE AND DESMETHYLCLOZAPINE IN SCHIZOPHRENIC-PATIENTS

被引:34
作者
LIN, SK
CHANG, WH
CHUNG, MC
LAM, YWF
JANN, MW
机构
[1] TAIPEI CITY PSYCHIAT CTR,BIOL PSYCHIAT LAB,TAIPEI 10510,TAIWAN
[2] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,DIV CLIN PHARM,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] MERCER UNIV,DEPT PHARM PRACTICE,ATLANTA,GA
[5] MERCER UNIV,DEPT PHARMACEUT SCI,ATLANTA,GA
关键词
D O I
10.1002/j.1552-4604.1994.tb02000.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of the atypical clozapine and its desmethyl metabolite were evaluated in fourteen male chronic patients. A single 100 mg dose of clozapine was administered and blood sampling performed over the following 72 hours. The mean (SD) oral clearance and half-life of clozapine were 55.4 (29.7) L/hr and 13.7 (9.9) hours, respectively. The mean (SD) AUC for clozapine and desmethylclozapine was 2389.9 (1406) and 751.1 (622.9) ng.hr/mL, respectively. The elimination of the metabolite is rate limited by its formation from cloza-pine. A wide interpatient variability in clozapine and desmethylclozapine pharmacokinetics was observed.
引用
收藏
页码:318 / 324
页数:7
相关论文
共 30 条
[1]   CLOZAPINE - PHARMACOKINETIC INVESTIGATIONS AND BIOCHEMICAL EFFECTS IN MAN [J].
ACKENHEIL, M .
PSYCHOPHARMACOLOGY, 1989, 99 :S32-S37
[2]   HOMOVANILLIC-ACID MEASUREMENT IN CLINICAL RESEARCH - A REVIEW OF METHODOLOGY [J].
AMIN, F ;
DAVIDSON, M ;
DAVIS, KL .
SCHIZOPHRENIA BULLETIN, 1992, 18 (01) :123-148
[3]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[4]  
CHANG WH, 1983, ACTA PHARMACOL TOX, V53, P275
[5]  
CHANG WH, 1987, PSYCHOPHARMACOLOGY, V93, P403
[6]   CLINICAL PHARMACOKINETICS OF CLOZAPINE IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
CHENG, YF ;
LUNDBERG, T ;
BONDESSON, U ;
LINDSTROM, L ;
GABRIELSSON, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (05) :445-449
[7]   SINGLE-DOSE VS MULTIPLE-DOSE PHARMACOKINETICS OF CLOZAPINE IN PSYCHIATRIC-PATIENTS [J].
CHOC, MG ;
HSUAN, F ;
HONIGFELD, G ;
ROBINSON, WT ;
ERESHEFSKY, L ;
CRISMON, ML ;
SAKLAD, SR ;
HIRSCHOWITZ, J ;
WAGNER, R .
PHARMACEUTICAL RESEARCH, 1990, 7 (04) :347-351
[8]   MULTIPLE-DOSE PHARMACOKINETICS OF CLOZAPINE IN PATIENTS [J].
CHOC, MG ;
LEHR, RG ;
HSUAN, F ;
HONIGFELD, G ;
SMITH, HT ;
BORISON, R ;
VOLAVKA, J .
PHARMACEUTICAL RESEARCH, 1987, 4 (05) :402-405
[9]   DISPOSITION OF PERPHENAZINE IS RELATED TO POLYMORPHIC DEBRISOQUIN HYDROXYLATION IN HUMAN-BEINGS [J].
DAHLPUUSTINEN, ML ;
LIDEN, A ;
ALM, C ;
NORDIN, C ;
BERTILSSON, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (01) :78-81
[10]  
DAVILA R, 1988, ARCH GEN PSYCHIAT, V45, P564